IMCRImmunocore Holdings plc
$31.03-7.5% 1Y
$31.03
$27.7952 weeks$40.22
Latest close: below its 200-day averageOct 23, 2026what changed →
Is the price fair?
What IMCR's price assumes
Immunocore Holdings plc did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.76× revenue.
3.76
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.86
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 3.86
- EV / EBIToperating margin −5.2%: the multiple describes the denominator
- not meaningful
- Market capitalisation51.5 million shares, counted Jul 31, 2026
- $1.60B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.